Psychedelics for Psych Conditions Made Their Mark in 2023
In January, we reported on an investigational psychedelic that alleviated symptoms of depression in a mid-stage trial. In this report, we follow up on what has happened since that study was published. In the phase IIa trial, an investigational N,N-dimethyltryptamine treatment — commonly known as the hallucinogen DMT — significantly reduced depressive symptoms by 7.4 […]